Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy L Ballinger

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2022
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studyMegan C Best, Nicci Bartley, Christine E Napier, et al.
Journal of Medical Genetics|January 26, 2020
Cancer patients' views and understanding of genome sequencing: a qualitative studyNicci Bartley, Megan Best, Chris Jacobs, et al.
Journal of Cellular and Molecular Medicine|September 17, 2009
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivoMandy L Ballinger, Narin Osman, Kazuhiko Hashimura, et al.
Archives of Biochemistry and Biophysics|June 12, 2012
Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylationPeter J Little, Robel Getachew, Hossein Babaahmadi Rezaei, et al.
Translational Oncology|May 26, 2020
Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular ProfilingGrace Davies, Phyllis Butow, Christine E Napier, et al.
Plos One|July 30, 2013
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohortGillian Mitchell, Mandy L Ballinger, Stephen Wong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2017
Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPROGang Peng, Jasmina Bojadzieva, Mandy L Ballinger, et al.
Future Oncology (London, England)|June 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST programDerrick H W Siu, Frank P Y Lin, David M Thomas, et al.
The Oncologist|May 7, 2024
From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient viewsMegan C Best, Phyllis Butow, Jacqueline Savard, et al.
The Journal of Biological Chemistry|January 1, 2010
Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathwaysLuiz E M Cardoso, Peter J Little, Mandy L Ballinger, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2022
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studyMegan C Best, Nicci Bartley, Christine E Napier, et al.
Journal of Medical Genetics|January 26, 2020
Cancer patients' views and understanding of genome sequencing: a qualitative studyNicci Bartley, Megan Best, Chris Jacobs, et al.
Journal of Cellular and Molecular Medicine|September 17, 2009
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivoMandy L Ballinger, Narin Osman, Kazuhiko Hashimura, et al.
Archives of Biochemistry and Biophysics|June 12, 2012
Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylationPeter J Little, Robel Getachew, Hossein Babaahmadi Rezaei, et al.
Translational Oncology|May 26, 2020
Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular ProfilingGrace Davies, Phyllis Butow, Christine E Napier, et al.
Plos One|July 30, 2013
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohortGillian Mitchell, Mandy L Ballinger, Stephen Wong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2017
Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPROGang Peng, Jasmina Bojadzieva, Mandy L Ballinger, et al.
Future Oncology (London, England)|June 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST programDerrick H W Siu, Frank P Y Lin, David M Thomas, et al.
The Oncologist|May 7, 2024
From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient viewsMegan C Best, Phyllis Butow, Jacqueline Savard, et al.
The Journal of Biological Chemistry|January 1, 2010
Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathwaysLuiz E M Cardoso, Peter J Little, Mandy L Ballinger, et al.
Pageof 9